May 28 (Reuters) - Quest Diagnostics on Thursday received emergency use authorization from the U.S. Food and Drug Administration for its self-collection COVID-19 test kit.
The test allows people to swab the front part of the nostril at home or in a healthcare setting when deemed necessary. (Reporting by Trisha Roy in Bengaluru; Editing by Amy Caren Daniel)